Chime Biologics and Y’s AC Announce Strategic Collaboration to Advance Anti-CD26 mAb in Refractory Cancers
Article Date
November 5, 2026
This article is featured on another website.
Go to article
August 14, 2026
From Bioprocessing to the Digital Age: Chime Biologics at the Bioprocessing Summit 2026
August 14, 2026
From Bioprocessing to the Digital Age: Chime Biologics at the Bioprocessing Summit 2026
August 11, 2026
The HiRO Growth Story: Creating a Global CRO Through Strategic Growth
Part 2 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
August 11, 2026
The HiRO Growth Story: Creating a Global CRO Through Strategic Growth
Part 2 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…